Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2165

1.

Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.

Avery AJ, Anderson C, Bond CM, Fortnum H, Gifford A, Hannaford PC, Hazell L, Krska J, Lee AJ, McLernon DJ, Murphy E, Shakir S, Watson MC.

Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200. Review.

PMID:
21545758
[PubMed - indexed for MEDLINE]
Free Article
2.

How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme.

Hazell L, Cornelius V, Hannaford P, Shakir S, Avery AJ; Yellow Card Study Collaboration.

Drug Saf. 2013 Mar;36(3):199-206. doi: 10.1007/s40264-013-0021-2.

PMID:
23444232
[PubMed - indexed for MEDLINE]
3.

The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective.

Anderson C, Krska J, Murphy E, Avery A; Yellow Card Study Collaboration.

Br J Clin Pharmacol. 2011 Nov;72(5):806-22. doi: 10.1111/j.1365-2125.2011.03990.x.

PMID:
21496066
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.

Inch J, Watson MC, Anakwe-Umeh S.

Drug Saf. 2012 Oct 1;35(10):807-18. doi: 10.2165/11631650-000000000-00000. Review.

PMID:
22928729
[PubMed - indexed for MEDLINE]
5.

First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.

Durrieu G, Palmaro A, Pourcel L, Caillet C, Faucher A, Jacquet A, Ouaret S, Perault-Pochat MC, Kreft-Jais C, Castot A, Lapeyre-Mestre M, Montastruc JL; French Network of Pharmacovigilance Centres.

Drug Saf. 2012 Oct 1;35(10):845-54. doi: 10.2165/11631800-000000000-00000.

PMID:
22967189
[PubMed - indexed for MEDLINE]
6.

Pharmacovigilance of herbal medicines : a UK perspective.

Barnes J.

Drug Saf. 2003;26(12):829-51. Review.

PMID:
12959628
[PubMed - indexed for MEDLINE]
7.

Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.

McLernon DJ, Bond CM, Hannaford PC, Watson MC, Lee AJ, Hazell L, Avery A; Yellow Card Collaboration.

Drug Saf. 2010 Sep 1;33(9):775-88. doi: 10.2165/11536510-000000000-00000.

PMID:
20701410
[PubMed - indexed for MEDLINE]
8.

Experiences with adverse drug reaction reporting by patients: an 11-country survey.

van Hunsel F, Härmark L, Pal S, Olsson S, van Grootheest K.

Drug Saf. 2012 Jan 1;35(1):45-60. doi: 10.2165/11594320-000000000-00000. Review.

PMID:
22149419
[PubMed - indexed for MEDLINE]
9.

Interpreting adverse drug reaction (ADR) reports as hospital patient safety incidents.

Davies EC, Green CF, Mottram DR, Pirmohamed M.

Br J Clin Pharmacol. 2010 Jul;70(1):102-8. doi: 10.1111/j.1365-2125.2010.03671.x.

PMID:
20642552
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Reported paediatric adverse drug reactions in the UK 2000-2009.

Hawcutt DB, Mainie P, Riordan A, Smyth RL, Pirmohamed M.

Br J Clin Pharmacol. 2012 Mar;73(3):437-46. doi: 10.1111/j.1365-2125.2011.04113.x. Review.

PMID:
21988288
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Survey to assess public awareness of patient reporting of adverse drug reactions in Great Britain.

Fortnum H, Lee AJ, Rupnik B, Avery A; Yellow Card Study Collaboration.

J Clin Pharm Ther. 2012 Apr;37(2):161-5. doi: 10.1111/j.1365-2710.2011.01273.x. Epub 2011 May 18.

PMID:
21592158
[PubMed - indexed for MEDLINE]
12.

Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: are there differences between males and females?

Light KP, Lovell AT, Butt H, Fauvel NJ, Holdcroft A.

Pharmacoepidemiol Drug Saf. 2006 Mar;15(3):151-60.

PMID:
16395661
[PubMed - indexed for MEDLINE]
13.

Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.

Aagaard L, Strandell J, Melskens L, Petersen PS, Holme Hansen E.

Drug Saf. 2012 Dec 1;35(12):1171-82. doi: 10.2165/11631940-000000000-00000.

PMID:
23072620
[PubMed - indexed for MEDLINE]
14.

Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example.

van Hunsel F, Passier A, van Grootheest K.

Br J Clin Pharmacol. 2009 May;67(5):558-64. doi: 10.1111/j.1365-2125.2009.03400.x. Epub 2009 Feb 26.

PMID:
19552751
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK.

McLernon DJ, Bond CM, Lee AJ, Watson MC, Hannaford PC, Fortnum H, Krska J, Anderson C, Murphy E, Avery A; Yellow Card Study Collaboration.

Pharmacoepidemiol Drug Saf. 2011 May;20(5):523-31. doi: 10.1002/pds.2117. Epub 2011 Feb 17.

PMID:
21328634
[PubMed - indexed for MEDLINE]
16.

How patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK Yellow Card Scheme.

Krska J, Anderson C, Murphy E, Avery AJ.

Drug Saf. 2011 May 1;34(5):429-36. doi: 10.2165/11589320-000000000-00000.

PMID:
21513365
[PubMed - indexed for MEDLINE]
17.

A patient's perspective: the impact of adverse drug reactions on patients and their views on reporting.

Lorimer S, Cox A, Langford NJ.

J Clin Pharm Ther. 2012 Apr;37(2):148-52. doi: 10.1111/j.1365-2710.2011.01258.x. Epub 2011 May 18.

PMID:
21592157
[PubMed - indexed for MEDLINE]
18.

Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study.

Leone R, Moretti U, D'Incau P, Conforti A, Magro L, Lora R, Velo G.

Drug Saf. 2013 Apr;36(4):267-76. doi: 10.1007/s40264-013-0028-8.

PMID:
23475583
[PubMed - indexed for MEDLINE]
19.

Non-medical prescribers and pharmacovigilance: participation, competence and future needs.

Stewart D, MacLure K, Paudyal V, Hughes C, Courtenay M, McLay J.

Int J Clin Pharm. 2013 Apr;35(2):268-74. doi: 10.1007/s11096-012-9739-7. Epub 2013 Jan 1.

PMID:
23277419
[PubMed - indexed for MEDLINE]
20.

Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006.

Aagaard L, Nielsen LH, Hansen EH.

Drug Saf. 2009;32(11):1067-74. doi: 10.2165/11316680-000000000-00000.

PMID:
19810778
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk